Valentine, K. D.
Cha, Tom
Giardina, John C.
Marques, Felisha
Atlas, Steven J.
Bedair, Hany
Chen, Antonia F.
Doorly, Terence
Kang, James
Leavitt, Lauren
Licurse, Adam
O’Brien, Todd
Sequist, Thomas
Sepucha, Karen
Article History
Received: 12 May 2021
Accepted: 5 November 2021
First Online: 19 November 2021
Declarations
:
: Informed consent was implied by completion of the survey, methods were performed in accordance with the relevant guidelines and regulations, and the study was approved by the Institutional Review Board at the Mass General Brigham HealthCare System (protocol 2005P002282).
: Not applicable.
: The authors have the following competing interests to declare: AC reports the following relevant financial activities outside the submitted work: Consultant: 3 M, Avanos, bOne, Convatec, DePuy, GLG, Heraeus, IrriMax, Pfizer, Recro, Stryker; Stocks: Graftworx, Joint Purification Systems, Sonoran, IrriMax, Hyalex, bOne; Publication royalties: SLACK Incorporated, UpToDate. JK reports the following relevant financial activities outside the submitted work: Shares of Stocks owned: ALung and Cardiorobotics (both non-orthopaedic/spine companies, no relevance to study). SAB/Consultant: OnPoint Surgical (augmented reality surgical guidance company). Deputy Editor of Spine Section: Journal of Orthopaedic Research. SA reports receiving royalty payments as a section editor of spinal disease and back pain for UpToDate, Inc. TC reports the following relevant financial activities outside submitted work: Institutional fellowship support: Nuvasive, OMEGA; Sponsored Research: NIH Grant Support; Consulting: Stryker, Nuvasive, Bio2. KS, KV, TC, HB, SA, FM, LL, and JG reported funding from Donaghue Foundation. TS reports that he is a consultant for Verily Life Sciences. HB reports royalties from and consulting with Exactech, Smith & Nephew and royalties from Wolters Kluver. TD, AL, and TO have no conflicts to report.